HERE IS MY TAKE ON THE AEI SITUATION. CHAN IS THE DUMBEST
HERE IS MY TAKE ON THE AEI SITUATION. CHAN IS THE DUMBEST INSIDER IN THE ENTIRE WORLD. IN APRIL ALONE, HE PURCHASED AT LEAST 5 MILLION COMMON SHARES OF AEI, WITH LAST PURCHASE BEING JUST HOURS PRIOR TO ANNOUNCING THE S-3. THIS S-3 WAS ANNOUNCED ON A MONDAY, WHICH MIGHT BE THE WORST DAY OF WEEK TO DO SO! USUALLY THEY TRY TO BURY BAD NEWS OVER THE WEEKEND.
SO NOW... JUST TO BE CLEAR CHAN BOUGHT MILLIONS OF DOLLARS WORTH OF AEI JUST HOURS AND DAYS AHEAD OF ANNOUNCING S-3 ON THE WORST DAY OF THE WEEK, KNOWING FULL WELL THOUSANDS WOULD PANIC SELL OUT OF IGNORANCE, CRUSHING THE PPS ALONG WITH IT, HIS INVESTMENT. IS THIS ALL MAKING GOOD SENSE YET? LOL
SERIOUSLY, CHAN IS THE BENEFICIAL OWNER OF SOME 44 MILLION SHARES OF AEI. FEW COULD ARGUE THAT CHAN GOT CAUGHT IN THE DARK. I'M SURE EVERYONE WOULD AGREE CHAN KNEW EXACTLY WHAT WAS COMING
THE (S-3). A SHELF OFFERING IS ACTUALLY A SMART MOVE. I LIKEN IT TO GETTING PRE-APPROVED FOR A MORTGAGE. THE MONEY IS THERE WHEN THE DEAL IS OPTIMAL AND THE TIMING IS JUST RIGHT. I BELIEVE THE SHELF LIFE IS 3 YEARS AND IT SAVES TIME AND AVOIDS MESSING WITH THE SEC WHEN THE TIME IS RIGHT AND CAN BE EXTENDED IF NOT FULLY USED WITHOUT PAIN. THE S-3 ALSO LOWERS THE ADMINISTRATIVE COSTS FOR AEI. SO ALL IN ALL, NOT A BAD MOVE IF USED PROPERLY.
AEI WAS NOT HURTING FOR CASH PRIOR TO S-3 ANNOUNCEMENT. THE S-3 WAS FOR A TOTAL OF 75M. COMMON SENSE TELLS ME CHAN IS LOOKING DOWN THE ROAD AT SOMETHING HUGE. THE S-3 WASN'T SUBMITTED SIMPLY BECAUSE CHAN GOT BORED.
THIS ISN'T CHAN'S FIRST RODEO, HE HAS BEEN AROUND A WHILE AND BEEN INVOLVED WITH SEVERAL DIFFERENT COMPANIES.
SO BOTTOM LINE IS, YOU EITHER BELIEVE CHAN IS A COMPLETE IDIOT WITH MONEY TO BURN... OR THAT CHAN KNOWS EXACTLY WHATS COMING DOWN THE PIKE, AND IS DOING EVERYTHING POSSIBLE/LEGAL TO EMBRACE THE SITUATION.
I MYSELF, CHOOSE TO BELIEVE THE LATTER. CHAN KNOWS, AND I BELIEVE SOMETHING ABSOLUTELY TREMENDOUS IS HEADED OUR WAY.
I WILL CONTINUE TO ACCUMULATE UNTIL SOMEONE CONVINCES ME I'M WRONG.
BEST OF LUCK TO EVERY ONE REGARDLESS OF WHAT YOU DO.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...
Continue Reading
A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...
Continue Reading
Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...
Continue Reading
Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...
Continue Reading
A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...
Continue Reading
A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....
Continue Reading
A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...
Continue Reading
Top 5 Most Recently Viewed Articles
The Rise of Mobile Shopping in the Holiday Season The 2024 holiday season has presented remarkable insights into consumer behavior, showcasing a notable 9% increase in online spending throughout the United States. This year's shopping frenzy, spanning from early November to the end of December, has seen consumers gravitate towards mobile devices for their purchases,...
Continue Reading
Exploring the Impact of Tariffs on Coffee Prices Recently, Sen. Elizabeth Warren (D-Mass.) criticized President Donald Trump during National Coffee Day, drawing attention to the rising costs of coffee that have resulted from his contentious tariff policies. While Trump expressed festive wishes associated with the day, Warren pointed out that these tariffs have caused...
Continue Reading
Replenish Nutrients Aims to Change the Game When a $15 million investment surfaces in the world of regenerative agriculture, you know someone means business. SRC Agrominerals throwing cash at Replenish Nutrients could shake things up big time. Imagine an investment poised to bump Replenish's owned capacity by fivefold. It's not pocket change; it's laying down tracks for...
Continue Reading
Understanding the Recent Class Action Lawsuits Law Offices of Howard G. Smith has alerted investors about ongoing class action lawsuits for several companies including Lantheus Holdings, Inc. (NASDAQ: LNTH), VF Corporation (NYSE: VFC), Fluor Corporation (NYSE: FLR), and Cytokinetics, Incorporated (NASDAQ: CYTK). Each case presents a unique opportunity for shareholders to...
Continue Reading
Growth of the Silanes Market Towards 2029 The silanes market has been observed to be on a significant growth trajectory, with forecasts predicting an increase from USD 3.62 billion in 2024 to USD 5.20 billion by 2029. This remarkable rise is associated with a compound annual growth rate (CAGR) of 7.5% over the coming years. The driving force behind this expansion can be...
Continue Reading